Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
(Celecoxib + tucidinostat) by Great Novel Therapeutics Biotech & Medicals for Metastatic Colorectal Cancer: Likelihood of Approval
(Celecoxib + tucidinostat) is under clinical development by Great Novel Therapeutics Biotech & Medicals and currently in Phase I for...